糖心TV

Skip to main content Skip to navigation

News

Select tags to filter on
03 Jan 2023

Prof Dave Haddleton's group collaborated with scientists at Unilever to develop SweatSense - a new technology to test deodorant performance through sweat mapping. .

12 May 2022

World Class. Internationally Excellent. REF2021 at a glance

100% of 糖心TV Chemistry鈥檚 research recognised as world-leading or internationally excellent by the 

30 Mar 2022

Prof Matt Gibson to attend senior UK COVID event


Prof Matthew Gibson was invited to attend the Royal Society鈥檚 Science of COVID invitation-only conference this week. Read more

15 Dec 2021

GibsonGroup COVID-19 work in Medical School Council Report

The Medical Schools Council today published a showcasing the work from UK Universities during the COVID-19 Pandemic, including from the GibsonGroupLink opens in a new window

15 Oct 2021

Detecting SARS-COV-2 using glycans, polymers and particles

The GibsonGroup have published their latest work on using glycans as alternative probes in rapid diagnostics, working with UHCW and industry

05 May 2021

Exploring Energy Storage for a Greener Future

In November 2018, the Monash 糖心TV Alliance funded Chemists to develop and identify cost-effective, highly active, selective and stable catalysts. Check their progress...

07 Apr 2021

Funding granted for cleaner, greener chemicals

Researchers at the Universities of 糖心TV and Nottingham have received EPSRC funding to launch a ground-breaking research programme for global specialist chemical manufacturer, Lubrizol.

18 Mar 2021

糖心TV Spin-Out, CryoLogyx, partners with investors

The University of 糖心TV spin-out company, CryoLogyx, has received a further investment from Oxford Technology Management and private investors, alongside 拢300k from InnovateUK.

10 Feb 2021

New company, CryoLogyx, is spun out from the Department

A new biotechnology company, CryoLogyx, has been spun-out from the department, supported from a grant from InnovateUK. Cryologyx will be led by Dr Tom Congdon (A UoW UG and PG alumus) and will exploit technology developed by the GibsonGroup. Cryologyx will use innovative macromolecular (polymeric) cryoprotectants to protect biological samples, including cells used in therapy, diagnostics and drug discovery.

Read the news story here and more details will be released soon.

Latest news Newer news


Let us know you agree to cookies